Cannabis Stocks in Focus: Trump Considers Downgrading Marijuana. Canopy Growth Rose After Numbers Last Week.

The trend of cannabis/marijuana must be kept in view now. According to a report by the Wall Street Journal, U.S. President Donald Trump is considering reclassifying marijuana as a less dangerous drug, specifically from Schedule I to Schedule III. This change could facilitate the sale and purchase of cannabis, provide tax advantages, and expand medical research. The Biden administration had similar plans but did not implement them. The stock of Canopy Growth (CGC) rose the previous week right after the release of its quarterly numbers. The company...